Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar CellBlock9 (96.36) Submitted: 8/18/2012 4:47:26 PM : Outperform Start Price: $51.92 VRX Score: +13.14

S&P 4 star-call

Featured Broker Partners


Advertisement